Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-046891
Filing Date
2024-11-14
Accepted
2024-11-14 16:05:54
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20034553_10q.htm   iXBRL 10-Q 1231965
2 EXHIBIT 31.1 ef20034553_ex31-1.htm EX-31.1 12240
3 EXHIBIT 31.2 ef20034553_ex31-2.htm EX-31.2 12097
4 EXHIBIT 32.1 ef20034553_ex32-1.htm EX-32.1 5053
5 EXHIBIT 32.2 ef20034553_ex32-2.htm EX-32.2 5023
11 image01.jpg GRAPHIC 35047
  Complete submission text file 0001140361-24-046891.txt   5506388

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20240930.xsd EX-101.SCH 33029
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20240930_cal.xml EX-101.CAL 34294
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20240930_def.xml EX-101.DEF 151272
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20240930_lab.xml EX-101.LAB 515554
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20240930_pre.xml EX-101.PRE 290557
61 EXTRACTED XBRL INSTANCE DOCUMENT ef20034553_10q_htm.xml XML 780301
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 241461938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)